Express News | CA Governor Newsom Proclaimed State Of Emergency To Further Enhance State's Preparedness And Accelerate The Bird Flu Cross-Agency Response Efforts
Express News | CDC Confirms First Severe Case Of H5N1 Bird Flu In U.S. On December 13; Patient Hospitalized With Severe Case Of Avian Influenza A Virus Infection In Louisiana
Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers
Cautious Outlook on GlaxoSmithKline: Sell Rating Due to Pipeline and Financial Challenges
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
GSK Gets CHMP Nod for Expanded Use of HIV Combo & Jemperli
Deutsche Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)
What's Going On Moderna Stock On Monday?
GSK's Jemperli Recommended for Expanded Approval in Endometrial Cancer, Receives Breakthrough Therapy Designation for Rectal Cancer
GSK Passes Three Significant Milestones With New Cancer Drug Given a Double Boost | LSE:GSK, NYSE:GSK
GSK's Rectal Cancer Treatment Receives Breakthrough Designation From US FDA
GSK's Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission
ViiV Healthcare Announces CHMP Positive Opinion for Vocabria + Rekambys, the First and Only Complete Long-acting HIV Treatment, for Adolescents in Europe
Jemperli (Dostarlimab) Plus Chemotherapy Receives Positive CHMP Opinion to Expand Approval to All Adult Patients With Primary Advanced or Recurrent Endometrial Cancer
GSK's B7-H3-targeted Antibody-drug Conjugate, GSK'227, Receives EMA Priority Medicines (PRIME) Designation in Relapsed Extensive-stage Small-cell Lung Cancer
Jemperli (Dostarlimab) Receives US FDA Breakthrough Therapy Designation for Locally Advanced DMMR/MSI-H Rectal Cancer
United Kingdom's National Health Service Drug Spending Priorities Questioned in New Analysis
Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
Barclays Remains a Hold on GlaxoSmithKline (GSK)
Top Gap Ups and Downs on Wednesday: MLI, MSTR, GSK and More
No Data